Upgrade to SI Premium - Free Trial

Cowen Defends Bausch Health Companies (BHC); 'Add Here'

February 19, 2020 11:37 AM
Cowen analyst Ken Cacciatore reiterated an Outperform rating and $40.00 price target on Bausch Health Companies (NYSE: BHC), saying there ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Trader Talk

Next Articles